Biotechnology sector ETFs weakened Wednesday as the Trump administration pushes forward plans to allow the importation of cheaper drugs in an attempt to create greater competition in response to the rising costs of U.S. drugs. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest...